Congratulations and Welcomes to UCI Urology Family

Dr. Michael Daneshvar is a fellowship trained urologic oncologist from the National Cancer Institute (NCI)/National Institutes of Health (NIH). He specializes in both robotic and open surgery for the treatment of kidney, bladder, prostate, testis, and penile cancer. Most recently, he worked alongside a multidisciplinary panel of national experts, to set guided recommendations for clinicians on genetic risk assessment in hereditary renal cell carcinoma (RCC). This will help guide certain treatment patterns for patients with hereditary disease. No matter the tumor size or location, patients will have better choices from diagnosis to treatment of their specific disease processes.

Dr. Akhil Das is fellowship trained in endourology and focuses on the management of lower urinary tract symptoms and minimally invasive therapies for BPH. He was one of the first surgeons to perform HoLEP in the USA and helped develop the surgical strategies to advance HoLEP as a minimally invasive technique for BPH. This procedure has remarkable outcomes for patients with prostate-based obstruction or other symptoms. Dr. Das was instrumental in making HoLEP a procedure of choice for BPH. In the revised 2018 AUA guidelines for BPH, HoLEP is now considered the primary endoscopic surgical technique independent of prostate size and arguably is the gold standard for the surgical management of BPH. We are very excited to now offer this largely outpatient procedure with a uniquely skilled practitioner.

Dr. Zhina Sadeghi is fellowship trained in neuro-urology, female and reconstructive urologic surgery from University of Michigan. Her expertise of urological diseases includes pelvic organ prolapse, urinary storage and voiding dysfunction (overactive bladder, urinary incontinence, etc.), urethral and bladder neck pathologies (diverticulum, stricture, etc.), neurogenic bladder, radiation cystitis, complications of urinary diversion and stomas, recurrent UTIs, urinary tract fistulas, evaluation and management of hydronephrosis, ureteral obstruction and stricture diseases. She performs outpatient and complex inpatient, vaginal and abdominal, endoscopic, open, and laparoscopic robotic surgeries. Her major scientific interest is translational studies of urinary system storage and voiding dysfunction including pathogenesis of urethral and bladder dysfunction, and investigation of novel multipotent cell therapy, and neuromodulation.

Dr. Olivia Chang is a urogynecologist, fellowship trained in female pelvic medicine and reconstructive surgery from Cleveland Clinic. She also is board-certified OB/GYN. Her expertise includes offers treatment on a variety of pelvic floor disorders, such as pelvic organ prolapse, urinary disorders (urinary incontinence, voiding dysfunction, incomplete bladder emptying), genitourinary fistulas. Dr. Chang also offers treatment for conditions which require reconstructive surgery, such as congenital anomalies (vaginal agenesis, vaginal septum), acquired conditions (radiation complications, labial hypertrophy) and gender-affirming surgeries (hysterectomy, salpingo-oophorectomy, complete vaginectomy, orchiectomy, clitoroplasty and urethroplasty).